18F-FDG PET/MR for diagnosis of primary central nervous system lymphoma: protocol for a systematic review and meta-analysis
View abstract on PubMed
Summary
This summary is machine-generated.This meta-analysis evaluates 18F-flourodeoxyglucose positron emission tomography (PET)/magnetic resonance (MR) for diagnosing primary central nervous system lymphoma (PCNSL). The study aims to determine the diagnostic validity of this combined imaging technique for PCNSL.
Area Of Science
- Oncology
- Radiology
- Medical Imaging
Background
- Primary central nervous system lymphoma (PCNSL) is a rare and aggressive non-Hodgkin's lymphoma.
- PCNSL has a generally poor prognosis, necessitating accurate and timely diagnosis.
- Combined PET/MR imaging offers potential advantages for evaluating brain lesions.
Purpose Of The Study
- To systematically evaluate the diagnostic accuracy of 18F-flourodeoxyglucose positron emission tomography (PET)/magnetic resonance (MR) for primary central nervous system lymphoma (PCNSL).
- To conduct a meta-analysis to determine the overall validity of PET/MR in PCNSL diagnosis.
Main Methods
- A comprehensive literature search of multiple databases (PubMed, Embase, Wanfang, SinoMed, CNKI, Cochrane Library) up to October 2024.
- Inclusion of studies reporting true positive, false positive, false negative, and true negative values for PET/MR in PCNSL diagnosis.
- Quality assessment using QUADAS, with meta-analysis performed using STATA and Meta-Disc software, including subgroup and sensitivity analyses.
Main Results
- This section is to be filled after the meta-analysis is completed.
- The meta-analysis will provide pooled diagnostic accuracy metrics for PET/MR in PCNSL.
- Heterogeneity will be explored through subgroup analysis, and robustness confirmed via sensitivity analysis.
Conclusions
- The findings will clarify the diagnostic performance of PET/MR for PCNSL.
- This meta-analysis will inform clinical practice regarding the utility of PET/MR in diagnosing PCNSL.
- Results will be disseminated through publication in a peer-reviewed journal.
Related Concept Videos
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Radioactive Tracer: PET involves using biologically active molecules labeled with radioactive isotopes, known as tracers or radiotracers. The...
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...

